NCT02564991

Brief Summary

Background: The way alcohol affects brain structure has been widely studied. But the way it affects all parts of the brain is still unknown. Researchers want to use magnetic resonance imaging (MRI) scans to study brain structure and function. They hope this will help them better understand changes that happen in brain regions during treatment of alcohol use disorders. Objectives: To study changes in the brain by using MRI in people with and without alcohol use disorders. To study how brain changes affect gait, balance, cognitive ability, and behavior. To see how the brain recovers when alcohol use stops. Eligibility: People with alcohol dependence who are currently hospitalized in a particular unit at NIH. Healthy volunteers 30 60 years old without an alcohol use disorder. Design: Participants will be screened under a separate protocol. Participants will give a urine sample for a drug test and pregnancy test at each study visit. They will also have to pass a breath alcohol test. At the first visit, participants will have an MRI. The scanner is a metal cylinder in a strong magnetic field. Participants will lie on a table that slides in and out of the cylinder. They will do behavior and memory tasks outside the scanner. They will have gait and balance tested. They will have to stand on both legs, stand on just one leg, and walk in a straight line. They will perform each task with eyes open, then with eyes closed. They will have tests of memory, thinking, and problem solving. Some participants will have a second visit. They will have another MRI and repeat some of the behavior and memory tasks. ...

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 30, 2015

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 1, 2015

Completed
5 months until next milestone

Study Start

First participant enrolled

February 29, 2016

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2020

Completed
Last Updated

May 6, 2024

Status Verified

May 1, 2024

Enrollment Period

4.1 years

First QC Date

September 30, 2015

Last Update Submit

May 3, 2024

Conditions

Keywords

AlcoholismMRIStructural MRICerebellumNatural History

Outcome Measures

Primary Outcomes (1)

  • The Primary outcome of this study is to assess recovery of cerebellar structure and function at the end of treatment compared to treatment entry measures.

    To assess recovery of cerebellar structure and function at the end oftreatment compared to treatment entry measures.

    Entry and End of Treatment

Study Arms (2)

Healthy Controls

125 non-substance abusing controls (NSAC)

Individuals with Alcohol Use Disorder

This group includes individuals who enrolled NIAAA alcohol treatment.

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy volunteers and Inpatient participants with alcohol use disorders. . Design Participants will receive whole-brain structural imaging and assessment of cerebellar function at the time of admission and again at the time of discharge

You may qualify if:

  • to 60 years old
  • Physically healthy
  • Healthy volunteers only: Currently consuming 7 or less standard drinks per week if female; 14 or less drinks per week if male.

You may not qualify if:

  • Significant history of head trauma or cranial surgery,
  • History of diabetes or stroke which requires medical intervention,
  • Clinical or laboratory evidence of severe hepatic disease as determined by ALT or AST greater than 5 times the upper normal limit, INR greater than 2.0, total bilirubin greater than 2.5 mg/dL, and albumin lower than 3.0 g/dL.
  • Positive HIV test.
  • Healthy volunteers only: 5 or more binge drinking episodes in the past 30 days (5 or more standard drinks on one occasion for males, 4 or more standard drinks on one occasion for females within two hours)
  • Healthy volunteers only:
  • Have fulfilled DSM-IV or DSM-5 criteria for current alcohol use disorder or substance abuse disorder
  • Inpatient participants only: Currently experiencing symptoms of withdrawal from alcohol (As determined by the most recent measurement within the past 30 days CIWA score \> 8)
  • Female participants only: Are currently pregnant
  • IPresence of any contraindication for fMRI as determined by the NIAAA MRI Safety Screening Questionnaire
  • Have calustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

Location

Related Links

MeSH Terms

Conditions

Chemically-Induced DisordersSubstance-Related DisordersMental DisordersAlcoholismAlcohol-Related Disorders

Study Officials

  • Reza Momenan, Ph.D.

    National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 30, 2015

First Posted

October 1, 2015

Study Start

February 29, 2016

Primary Completion

March 18, 2020

Study Completion

March 18, 2020

Last Updated

May 6, 2024

Record last verified: 2024-05

Locations